Skip to main content
Top
Published in: Clinical Research in Cardiology 2/2017

01-02-2017 | Original Paper

Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population

Authors: Matthias Bossard, Sébastien Thériault, Stefanie Aeschbacher, Tobias Schoen, Seraina Kunz, Mirco von Rotz, Joel Estis, John Todd, Martin Risch, Christian Mueller, Lorenz Risch, Guillaume Paré, David Conen

Published in: Clinical Research in Cardiology | Issue 2/2017

Login to get access

Abstract

Background

Determinants of cardiomyocyte injury as quantified by high-sensitivity cardiac troponin I (cTnI) in young and healthy individuals, and sex-specific 99th percentiles are largely unknown.

Methods

Our study included 2077 adults from the general population aged 25–41 years without cardiovascular disease. cTnI was measured using a high-sensitivity assay. We performed stepwise backward linear regression analyses to identify variables independently associated with hs-cTnI levels, and calculated narrow-sense heritability from 1638-genotyped participants.

Results

Median age was 37 years. cTnI was quantifiable in all but 11 participants (99.5 %). Median (interquartile range) cTnI was significantly higher in men than in women [0.99 (0.71; 1.65) versus 0.47 (0.33; 0.71) ng/L, p < 0.0001]. The 99th percentile of cTnI was 15.79 ng/L in men and 5.11 ng/L in women. Out of 46 variables, 22 independent determinants for cTnI were identified. The strongest associations were observed with sex, age, systolic blood pressure, heart rate, left ventricular mass, N-terminal pro B-type natriuretic peptide, and creatine kinase (all p < 0.0001). The final model explained 36 % of the overall cTnI variability. Heritability of cTnI was estimated to be 29 % (p = 0.005), but became non-significant when the residuals of the multivariable model were used for analysis (5 %, p = 0.36).

Conclusions

Sex, age, and systolic blood pressure belong to the strongest determinants of hs-cTnI in healthy adults. The 99th percentile was three times higher in men compared to women. Hence, sex-specific cut-off values may be preferable when applying hs-cTnI for screening purposes. Our results may also improve the interpretation of cTn levels in daily clinical practice.
Appendix
Available only for authorised users
Literature
3.
go back to reference de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK (2010) Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA J Am Med Assoc 304(22):2503–2512. doi:10.1001/jama.2010.1768 CrossRef de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK (2010) Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA J Am Med Assoc 304(22):2503–2512. doi:10.​1001/​jama.​2010.​1768 CrossRef
4.
go back to reference Masson S, Latini R, Mureddu GF, Agabiti N, Miceli M, Cesaroni G, Forastiere F, Wienhues-Thelen UH, Block D, Zaugg C, Vago T, Boccanelli A, study P (2013) High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals. J Intern Med 273(3):306–317. doi:10.1111/joim.12023 CrossRefPubMed Masson S, Latini R, Mureddu GF, Agabiti N, Miceli M, Cesaroni G, Forastiere F, Wienhues-Thelen UH, Block D, Zaugg C, Vago T, Boccanelli A, study P (2013) High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals. J Intern Med 273(3):306–317. doi:10.​1111/​joim.​12023 CrossRefPubMed
5.
go back to reference Zeller T, Tunstall-Pedoe H, Saarela O, Ojeda F, Schnabel RB, Tuovinen T, Woodward M, Struthers A, Hughes M, Kee F, Salomaa V, Kuulasmaa K, Blankenberg S, Investigators M (2014) High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 35(5):271–281. doi:10.1093/eurheartj/eht406 CrossRefPubMed Zeller T, Tunstall-Pedoe H, Saarela O, Ojeda F, Schnabel RB, Tuovinen T, Woodward M, Struthers A, Hughes M, Kee F, Salomaa V, Kuulasmaa K, Blankenberg S, Investigators M (2014) High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 35(5):271–281. doi:10.​1093/​eurheartj/​eht406 CrossRefPubMed
7.
go back to reference Apple FS, Steffen LM, Pearce LA, Murakami MM, Luepker RV (2012) Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey. Clin Chem 58(5):930–935. doi:10.1373/clinchem.2011.179176 CrossRefPubMed Apple FS, Steffen LM, Pearce LA, Murakami MM, Luepker RV (2012) Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey. Clin Chem 58(5):930–935. doi:10.​1373/​clinchem.​2011.​179176 CrossRefPubMed
8.
9.
go back to reference Neumann JT, Havulinna AS, Zeller T, Appelbaum S, Kunnas T, Nikkari S, Jousilahti P, Blankenberg S, Sydow K, Salomaa V (2014) Comparison of three troponins as predictors of future cardiovascular events—prospective results from the FINRISK and BiomaCaRE studies. PLoS One 9(3):e90063. doi:10.1371/journal.pone.0090063 CrossRefPubMedPubMedCentral Neumann JT, Havulinna AS, Zeller T, Appelbaum S, Kunnas T, Nikkari S, Jousilahti P, Blankenberg S, Sydow K, Salomaa V (2014) Comparison of three troponins as predictors of future cardiovascular events—prospective results from the FINRISK and BiomaCaRE studies. PLoS One 9(3):e90063. doi:10.​1371/​journal.​pone.​0090063 CrossRefPubMedPubMedCentral
10.
go back to reference Omland T, de Lemos JA, Holmen OL, Dalen H, Benth JS, Nygard S, Hveem K, Rosjo H (2015) Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study. Clin Chem. doi:10.1373/clinchem.2014.234369 Omland T, de Lemos JA, Holmen OL, Dalen H, Benth JS, Nygard S, Hveem K, Rosjo H (2015) Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study. Clin Chem. doi:10.​1373/​clinchem.​2014.​234369
12.
go back to reference Aeschbacher S, Schoen T, Bossard M, van der Lely S, Glattli K, Todd J, Estis J, Risch M, Mueller C, Risch L, Conen D (2014) Relationship between high-sensitivity cardiac troponin I and blood pressure among young and healthy adults. Am J Hypertens. doi:10.1093/ajh/hpu226 PubMed Aeschbacher S, Schoen T, Bossard M, van der Lely S, Glattli K, Todd J, Estis J, Risch M, Mueller C, Risch L, Conen D (2014) Relationship between high-sensitivity cardiac troponin I and blood pressure among young and healthy adults. Am J Hypertens. doi:10.​1093/​ajh/​hpu226 PubMed
13.
go back to reference Sinning C, Keller T, Zeller T, Ojeda F, Schluter M, Schnabel R, Lubos E, Bickel C, Lackner KJ, Diemert P, Munzel T, Blankenberg S, Wild PS, Gutenberg Health S (2014) Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study. Clin Res Cardiol Off J German Cardiac Soc 103(3):211–222. doi:10.1007/s00392-013-0640-8 CrossRef Sinning C, Keller T, Zeller T, Ojeda F, Schluter M, Schnabel R, Lubos E, Bickel C, Lackner KJ, Diemert P, Munzel T, Blankenberg S, Wild PS, Gutenberg Health S (2014) Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study. Clin Res Cardiol Off J German Cardiac Soc 103(3):211–222. doi:10.​1007/​s00392-013-0640-8 CrossRef
14.
15.
go back to reference Blankenberg S, Salomaa V, Makarova N, Ojeda F, Wild P, Lackner KJ, Jorgensen T, Thorand B, Peters A, Nauck M, Petersmann A, Vartiainen E, Veronesi G, Brambilla P, Costanzo S, Iacoviello L, Linden G, Yarnell J, Patterson CC, Everett BM, Ridker PM, Kontto J, Schnabel RB, Koenig W, Kee F, Zeller T, Kuulasmaa K, BiomarCa REI (2016) Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J. doi:10.1093/eurheartj/ehw172 PubMedCentral Blankenberg S, Salomaa V, Makarova N, Ojeda F, Wild P, Lackner KJ, Jorgensen T, Thorand B, Peters A, Nauck M, Petersmann A, Vartiainen E, Veronesi G, Brambilla P, Costanzo S, Iacoviello L, Linden G, Yarnell J, Patterson CC, Everett BM, Ridker PM, Kontto J, Schnabel RB, Koenig W, Kee F, Zeller T, Kuulasmaa K, BiomarCa REI (2016) Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J. doi:10.​1093/​eurheartj/​ehw172 PubMedCentral
16.
go back to reference Conen D, Schon T, Aeschbacher S, Pare G, Frehner W, Risch M, Risch L (2013) Genetic and phenotypic determinants of blood pressure and other cardiovascular risk factors (GAPP). Swiss Med Week 143:w13728. doi:10.4414/smw.2013.13728 Conen D, Schon T, Aeschbacher S, Pare G, Frehner W, Risch M, Risch L (2013) Genetic and phenotypic determinants of blood pressure and other cardiovascular risk factors (GAPP). Swiss Med Week 143:w13728. doi:10.​4414/​smw.​2013.​13728
17.
go back to reference Todd J, Freese B, Lu A, Held D, Morey J, Livingston R, Goix P (2007) Ultrasensitive flow-based immunoassays using single-molecule counting. Clin Chem 53(11):1990–1995CrossRefPubMed Todd J, Freese B, Lu A, Held D, Morey J, Livingston R, Goix P (2007) Ultrasensitive flow-based immunoassays using single-molecule counting. Clin Chem 53(11):1990–1995CrossRefPubMed
19.
go back to reference Krisai P, Aeschbacher S, Schoen T, Bossard M, van der Stouwe JG, Dorig L, Todd J, Estis J, Risch M, Risch L, Conen D (2015) Glucagon-like peptide-1 and blood pressure in young and healthy adults from the general population. Hypertension 65(2):306–312. doi:10.1161/HYPERTENSIONAHA.114.04718 CrossRefPubMed Krisai P, Aeschbacher S, Schoen T, Bossard M, van der Stouwe JG, Dorig L, Todd J, Estis J, Risch M, Risch L, Conen D (2015) Glucagon-like peptide-1 and blood pressure in young and healthy adults from the general population. Hypertension 65(2):306–312. doi:10.​1161/​HYPERTENSIONAHA.​114.​04718 CrossRefPubMed
20.
go back to reference Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, Investigators C-E (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367(1):20–29. doi:10.1056/NEJMoa1114248 CrossRefPubMedPubMedCentral Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, Investigators C-E (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367(1):20–29. doi:10.​1056/​NEJMoa1114248 CrossRefPubMedPubMedCentral
21.
go back to reference American Diabetes Association (2012) Standards of medical care in diabetes–2012. Diabetes Care 35(Suppl 1):S11–S63. doi:10.2337/dc12-s011 American Diabetes Association (2012) Standards of medical care in diabetes–2012. Diabetes Care 35(Suppl 1):S11–S63. doi:10.​2337/​dc12-s011
22.
go back to reference Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575. doi:10.1086/519795 CrossRefPubMedPubMedCentral Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575. doi:10.​1086/​519795 CrossRefPubMedPubMedCentral
24.
go back to reference McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ, Redfield MM, Burnett JC Jr, Jaffe AS (2013) Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem 59(7):1099–1107CrossRefPubMed McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ, Redfield MM, Burnett JC Jr, Jaffe AS (2013) Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem 59(7):1099–1107CrossRefPubMed
26.
go back to reference Eggers KM, Lind L, Ahlstrom H, Bjerner T, Ebeling Barbier C, Larsson A, Venge P, Lindahl B (2008) Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 29(18):2252–2258. doi:10.1093/eurheartj/ehn327 CrossRefPubMed Eggers KM, Lind L, Ahlstrom H, Bjerner T, Ebeling Barbier C, Larsson A, Venge P, Lindahl B (2008) Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 29(18):2252–2258. doi:10.​1093/​eurheartj/​ehn327 CrossRefPubMed
27.
go back to reference Gidding SS, Liu K, Colangelo LA, Cook NL, Goff DC, Glasser SP, Gardin JM, Lima JA (2013) Longitudinal determinants of left ventricular mass and geometry: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circ Cardiovasc Imaging 6(5):769–775. doi:10.1161/CIRCIMAGING.112.000450 CrossRefPubMed Gidding SS, Liu K, Colangelo LA, Cook NL, Goff DC, Glasser SP, Gardin JM, Lima JA (2013) Longitudinal determinants of left ventricular mass and geometry: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circ Cardiovasc Imaging 6(5):769–775. doi:10.​1161/​CIRCIMAGING.​112.​000450 CrossRefPubMed
28.
go back to reference Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, Cruikshank A, Reid A, Stoddart M, Strachan F, Walker S, Collinson PO, Apple FS, Gray AJ, Fox KA, Newby DE, Mills NL (2015) High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 350:g7873. doi:10.1136/bmj.g7873 CrossRefPubMedPubMedCentral Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, Cruikshank A, Reid A, Stoddart M, Strachan F, Walker S, Collinson PO, Apple FS, Gray AJ, Fox KA, Newby DE, Mills NL (2015) High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 350:g7873. doi:10.​1136/​bmj.​g7873 CrossRefPubMedPubMedCentral
29.
go back to reference Mueller-Hennessen M, Lindahl B, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Santalo-Bel M, Panteghini M, Plebani M, Verschuren F, Jernberg T, French JK, Christenson RH, Body R, McCord J, Dilba P, Katus HA, Mueller C, Investigators T-A (2016) Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T—Sub-analysis from the TRAPID-AMI study. Int J Cardiol 209:26–33. doi:10.1016/j.ijcard.2016.01.213 CrossRefPubMed Mueller-Hennessen M, Lindahl B, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Santalo-Bel M, Panteghini M, Plebani M, Verschuren F, Jernberg T, French JK, Christenson RH, Body R, McCord J, Dilba P, Katus HA, Mueller C, Investigators T-A (2016) Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T—Sub-analysis from the TRAPID-AMI study. Int J Cardiol 209:26–33. doi:10.​1016/​j.​ijcard.​2016.​01.​213 CrossRefPubMed
30.
go back to reference Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J, Thyroid Studies C (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA J Am Med Assoc 304(12):1365–1374. doi:10.1001/jama.2010.1361 CrossRef Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J, Thyroid Studies C (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA J Am Med Assoc 304(12):1365–1374. doi:10.​1001/​jama.​2010.​1361 CrossRef
31.
go back to reference Chan W, Taylor AJ, Ellims AH, Lefkovits L, Wong C, Kingwell BA, Natoli A, Croft KD, Mori T, Kaye DM, Dart AM, Duffy SJ (2012) Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Intervent 5(2):270–278. doi:10.1161/CIRCINTERVENTIONS.111.966226 CrossRef Chan W, Taylor AJ, Ellims AH, Lefkovits L, Wong C, Kingwell BA, Natoli A, Croft KD, Mori T, Kaye DM, Dart AM, Duffy SJ (2012) Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Intervent 5(2):270–278. doi:10.​1161/​CIRCINTERVENTION​S.​111.​966226 CrossRef
32.
go back to reference Wildi K, Haaf P, Reichlin T, Acemoglu R, Schneider J, Balmelli C, Drexler B, Twerenbold R, Mosimann T, Reiter M, Mueller M, Ernst S, Ballarino P, Zellweger C, Moehring B, Vilaplana C, Freidank H, Mueller C (2013) Uric acid for diagnosis and risk stratification in suspected myocardial infarction. Eur J Clin Invest 43(2):174–182. doi:10.1111/eci.12029 CrossRefPubMed Wildi K, Haaf P, Reichlin T, Acemoglu R, Schneider J, Balmelli C, Drexler B, Twerenbold R, Mosimann T, Reiter M, Mueller M, Ernst S, Ballarino P, Zellweger C, Moehring B, Vilaplana C, Freidank H, Mueller C (2013) Uric acid for diagnosis and risk stratification in suspected myocardial infarction. Eur J Clin Invest 43(2):174–182. doi:10.​1111/​eci.​12029 CrossRefPubMed
33.
go back to reference Pennell DJ, Porter JB, Piga A, Lai Y, El-Beshlawy A, Belhoul KM, Elalfy M, Yesilipek A, Kilinc Y, Lawniczek T, Habr D, Weisskopf M, Zhang Y, Aydinok Y, Investigators Cs (2014) A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in beta-thalassemia major (CORDELIA). Blood 123(10):1447–1454. doi:10.1182/blood-2013-04-497842 CrossRefPubMedPubMedCentral Pennell DJ, Porter JB, Piga A, Lai Y, El-Beshlawy A, Belhoul KM, Elalfy M, Yesilipek A, Kilinc Y, Lawniczek T, Habr D, Weisskopf M, Zhang Y, Aydinok Y, Investigators Cs (2014) A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in beta-thalassemia major (CORDELIA). Blood 123(10):1447–1454. doi:10.​1182/​blood-2013-04-497842 CrossRefPubMedPubMedCentral
36.
go back to reference Stacy SR, Suarez-Cuervo C, Berger Z, Wilson LM, Yeh HC, Bass EB, Michos ED (2014) Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review. Ann Intern Med 161(7):502–512. doi:10.7326/M14-0746 CrossRefPubMed Stacy SR, Suarez-Cuervo C, Berger Z, Wilson LM, Yeh HC, Bass EB, Michos ED (2014) Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review. Ann Intern Med 161(7):502–512. doi:10.​7326/​M14-0746 CrossRefPubMed
37.
go back to reference Yu B, Barbalic M, Brautbar A, Nambi V, Hoogeveen RC, Tang W, Mosley TH, Rotter JI, deFilippi CR, O’Donnell CJ, Kathiresan S, Rice K, Heckbert SR, Ballantyne CM, Psaty BM, Boerwinkle E, Consortium CA (2013) Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies. Circulation Cardiovascular genetics 6(1):82–88. doi:10.1161/CIRCGENETICS.112.963058 CrossRefPubMed Yu B, Barbalic M, Brautbar A, Nambi V, Hoogeveen RC, Tang W, Mosley TH, Rotter JI, deFilippi CR, O’Donnell CJ, Kathiresan S, Rice K, Heckbert SR, Ballantyne CM, Psaty BM, Boerwinkle E, Consortium CA (2013) Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies. Circulation Cardiovascular genetics 6(1):82–88. doi:10.​1161/​CIRCGENETICS.​112.​963058 CrossRefPubMed
38.
39.
go back to reference Conen D, Zeller A, Pfisterer M, Martina B (2006) Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol 97(2):249–252. doi:10.1016/j.amjcard.2005.08.028 CrossRefPubMed Conen D, Zeller A, Pfisterer M, Martina B (2006) Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol 97(2):249–252. doi:10.​1016/​j.​amjcard.​2005.​08.​028 CrossRefPubMed
Metadata
Title
Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population
Authors
Matthias Bossard
Sébastien Thériault
Stefanie Aeschbacher
Tobias Schoen
Seraina Kunz
Mirco von Rotz
Joel Estis
John Todd
Martin Risch
Christian Mueller
Lorenz Risch
Guillaume Paré
David Conen
Publication date
01-02-2017
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 2/2017
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-1026-5

Other articles of this Issue 2/2017

Clinical Research in Cardiology 2/2017 Go to the issue